Research analysts covering Lichen International.
Recent press releases and 8-K filings for LICN.
Lichen International Limited Reports Q2 2025 Results, Announces Strategic Shift and Recent Corporate Actions
LICN
Earnings
M&A
New Projects/Investments
- Lichen International Limited reported a net loss of ($9.182 million) for the six months ended June 30, 2025, compared to a net income of $0.767 million for the same period in 2024. Total revenues for the six months ended June 30, 2025, were $14.26 million, marking a 21.2% decrease from $18.10 million in the prior year period.
- The company is undergoing a strategic shift from 2025, gradually transitioning towards IPO advisory services and external equity investments, while winding down its education support services.
- Key corporate actions include changing its name to Lichen International Limited on February 10, 2025, implementing a one-for-two-hundred (1:200) reverse stock split on March 3, 2025, and completing the acquisition of the remaining 40% equity interest in Bondly HK for US$5,330,000 on February 26, 2025.
- On September 19, 2025, the company closed a private placement, selling up to 15,500,000 Class A ordinary shares at $1.20 per share, which generated approximately $18,600,000 in gross proceeds.
Sep 19, 2025, 8:31 PM
Lichen International Limited Completes Private Placement of Class A Ordinary Shares
LICN
- Lichen International Limited entered into securities purchase agreements on September 15, 2025, for the issuance and sale of 15,500,000 Class A ordinary shares.
- The shares were sold at a price of $1.20 per share, resulting in a total purchase price of $18,600,000, which was paid in cash.
- The company received the purchase price and issued the shares on September 19, 2025, through a private placement exempt from registration requirements.
Sep 19, 2025, 8:15 PM
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more